news
Obesity and Psoriasis: New Approach Targets Both Conditions
A new webinar from El Médico Interactivo highlights findings from the TOGETHER-PsA study, pushing for an integrated care standard for obesity and psoriatic disease. The research suggests that treating both conditions together, rather than separately, could improve patient outcomes. This points to a shift in how these common inflammatory states are viewed and managed.
A new webinar from El Médico Interactivo highlights findings from the TOGETHER-PsA study, pushing for an integrated care standard for obesity and psoriatic disease. The research suggests that treating both conditions together, rather than separately, could improve patient outcomes. This points to a shift in how these common inflammatory states are viewed and managed.
The architecture take
The medical world is finally catching up to what your body already knows: inflammation isn't a siloed event. This webinar, centered on psoriatic disease and obesity, makes a case for treating them as intertwined, not just co-occurring. For too long, the industry has handled these as separate issues, hitting the skin with one drug and the metabolism with another, missing the deeper systemic signal. This isn't just about weight loss improving skin; it's about acknowledging a shared inflammatory pathway that drives both conditions. I'm seeing more and more of this 'one body, many manifestations' thinking, which means we might actually start addressing root causes instead of playing whack-a-mole with symptoms. Watch for new therapeutic approaches that don't just target skin or fat, but the inflammatory state underneath them both. That's a real shift in care.